HealthLinx, Inex Innovations Exchange, Quest Laboratories, Medison sales and marketing update

Inex launched HealthLinx's OvPlex ovarian cancer diagnostic in Singapore. Inex has exclusive rights under a 2009 deal to market and distribute the first-generation test that measures five biomarkers in Singapore, Malaysia, India Thailand, Indonesia and Vietnam for 10 years. Inex has an option to extend the deal by an additional 10 years. Quest Laboratories, an independent laboratory, is providing the test in Singapore for S$300 ($223.11). ...